Australian (ASX) Stock Market Forum

KZA - Kazia Therapeutics

Jump to new
imaginator said:
What do u think of the recent reversal of NRT?

The volume looks low. Looks like someone is trying to push it up.
Click to expand...

Volumes are good IMO! Last week we had a highest single day volume in over 12 months. Weekly volume is averaging very high & looks like it will keep going that way.

Way oversold hence IMO we are seeing a re-rating. It came a lot quicker than expected though, straight after the tax-loss selling was complete.

I am stoked & have acumulated more - come December sub-$5 will be a thing of the past

cheers
 
An MD of Novogen has been reported as using offshore havens for tax avoidance. Maybe there has been insider trading?
 
ray223 said:
Today NRT is up 15%, 800,000 plus shares were traded after market. Something's up.
Click to expand...

You might be right, but NRT has been swinging up and down like crazy for the last few weeks. It wouldn't surprise me to see a 15% drop next week.
Still good buying IMO, but need to be patient.
 
This stock is at an interesting juncture.

This daily chart with 2.40 as support for the last nine months may highlight a entry point with evidence of longer term support for the STOP. One to watch over the next days / weeks
 

Attachments

  • NRT - 20070309.gif
    NRT - 20070309.gif
    57.2 KB · Views: 54
NRT

Anyone know what is happening with Novogen? Seems it has been the slide for a while. They seem to be taking their time getting approval
 
It seems to me "WE HAVE ALL" missed the boat on the NRT

I don't know about you?
but
Heads are going to roll on my Ship!!!!!!

Salute and Gods' speed
 

Attachments

  • NRT.png
    NRT.png
    12.4 KB · Views: 62
and now its 2010 the stock is in trading halt pending phase 111 results and we have a sp of .395 , i was told buy a broker in 2004 that this stock will be $45 in 2005......what a joke.....many a finger burnt on this one ...::banghead:
 
kariba said:
Volumes are good IMO! Last week we had a highest single day volume in over 12 months. Weekly volume is averaging very high & looks like it will keep going that way.

Way oversold hence IMO we are seeing a re-rating. It came a lot quicker than expected though, straight after the tax-loss selling was complete.

I am stoked & have acumulated more - come December sub-$5 will be a thing of the past

cheers
Click to expand...

lol now 2010 and were at .12 and now looks like nrt will fold selling its ideas to mshl ....oh !nrt owns 75%of mshl already .....how dose that work ?????
 
NRT Novogen

Hi i am new to this board, does anyone know much about NRT, been told to invest. cheers.
 
pixel said:
Today's announcement: http://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=01465615
caused quite a stir. Pity nobody raised an early alert. An entry sometime in October would have been interesting.
Click to expand...

Read the announcement and remembered how it ran in Feb this year, I decided to take a punt. I was too slow @ 25c on open and ended up reaching for it at 29c. I got chopped out at 34c or so and kicked myself madly when it raced to 39. But as with almost all pops, the afternoon fade was inevitable.

I actually dislike trading this kind of stocks as it requires full attention, and I can never exit at a price that makes me feel good, even though I made a small profit.
 
On November 29th, 2017, Novogen Limited (NRT) changed its name and ASX code to Kazia Therapeutics Limited (KZA).
 
Darc Knight said:
@Ann November 2017 this company did a Consolidation, then changed its name to KaziaTherapeutics Limited (KZA).
Click to expand...

Thanks DK, good man!

I have no idea why these companies change their names. You can see the full history on the chart under any name and the ASX notices link to the old company. They say "A rose by any other name would smell as sweet", all I am smelling is the same old fertilizer.

Announced 30/10/17....10 to 1 Share Consolidation which was legal theft and stripped the investors in this company of most or all of their investment.

Then after the Consolidation and name change.....

18/10/2018 The company completes a placement of KZA shares, primarily to sector-specialist institutional investors in Australia and internationally, at a price of A$0.38 per share. The placement will raise approximately A$3.4 million. Kazia will launch a share purchase plan to allow eligible existing holders of KZA securities the opportunity to acquire new fully-paid ordinary shares on the same terms as the placement. The SPP will open on Tuesday 23 October 2018.

Watch out for the Pump and Dump. These guys will want to see a profit from their investment, so far this little rose appears to be withering on its thorny little stem.

Putting up an 18 month chart without comment. No support/resistance lines, no volumes, no MACD, no wavin' movin' averages, no money flow by any flavour, no fibonaccis, not even my fave the PVI have a little eyeball practice, is this stock going up, sideways or down?
kza 9.1.19.png



WEALTH WARNING: This stock has been subject to a Consolidation in the past and may at some time in the future cause you to lose all your invested capital. Better value elsewhere.
 
NRT (Novogen) is now Kazia (KZA) and the broom has been swept through the joint under the new CEO (appointed a couple of years ago now).

One brain cancer drug in multiple phase II trials by different institutions in USA and Oz. Initial results hold some promise.

One ovarian cancer drug in advanced phase I trials with some indications of efficacy.

The company runs on the smell of an oily rag with not much cash in the kitty.

Very thinly traded stock (market cap was approx $32m at close yesterday from memory). It filled the gap that opened up on 20 June 2018 this morning. It's rallying hard off its all time lows.

upload_2019-3-6_10-53-24.png


In the long run the value of the business will be determined by the efficacy of its drugs, but with such a miniscule market cap, it might get swooped up before clinical trials are even completed.
 
tinhat said:
NRT (Novogen) is now Kazia (KZA) and the broom has been swept through the joint under the new CEO (appointed a couple of years ago now).

One brain cancer drug in multiple phase II trials by different institutions in USA and Oz. Initial results hold some promise.

One ovarian cancer drug in advanced phase I trials with some indications of efficacy.

The company runs on the smell of an oily rag with not much cash in the kitty.

Very thinly traded stock (market cap was approx $32m at close yesterday from memory). It filled the gap that opened up on 20 June 2018 this morning. It's rallying hard off its all time lows.

View attachment 92710

In the long run the value of the business will be determined by the efficacy of its drugs, but with such a miniscule market cap, it might get swooped up before clinical trials are even completed.
Click to expand...

thanks, tinstar!

2 ?'s

1 what's the break-up value ?
2 when is the likely cap-raise date ?
 

Similar threads

L
SNT - Syntara Limited
2 3
Replies
48
Views
16K
System
System
Top